These benefits were independent of baseline HbA1c and occurred without an increased risk of hypoglycemia [94]
Clinical trials show that approximately 10-15% of patients may be considered "non-responders" who lose less than 5% of body weight after 3-4 months on a maintenance dose
The Peter Attia Drive 112:21 Longevity 101: a foundational guide to Peter's frameworks for longevity, and understanding CVD, cancer, neurodegenerative disease, nutrition, exercise, sleep, and more (re-broadcast) The Peter Attia Drive 85:25 #370 - AMA #76: Peter evaluates longevity drugs, aspirin for CVD, and strategies to improve muscle mass proven, promising, fuzzy, noise, or nonsense
Our clinical data indicates that 85 percent of patients who follow our structured maintenance protocols maintain their weight loss for 24 months and beyond
Everything in Core, plus unlimited coaching, Workshops, and access to the GLP-1 Success Program with side-effect support and medication tracking